ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 153325 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 153325; 2) Community: the network communities that were significantly associated with the response to NSC 153325; 3) Molecule: the relationships between components within communities and NSC 153325; 4) MDR: the compounds that were significantly associated with the NSC 153325.

NSC Compound Enrichment Correlation
NSC 758662 Lovastatin [USAN] 0.0131142867047947 -0.054783703
NSC 105827 SANGIVAMYCIN,-THIO 0.0131142867047949 0.058471296
NSC 181500 Null 0.0135712240673827 0.34693273
NSC 271674 Carboxyphthalatoplatinum 0.0135712240673827 0.30249514
NSC 317917 1-Propanone, 3-(dimethylamino)-2-[(dimethylamino)methyl]-1-(4-methoxyphenyl)-, dihydrochloride 0.0135712240673827 0.37979191
NSC 626161 2-Hydroxy discorhabdin D 0.0135712240673827 0.38512774
NSC 627745 Null 0.0135712240673827 0.39509934
NSC 648322 Incarnal 0.0135712240673827 0.39224553
NSC 657321 1,9-Dioxacyclohexadeca-3,11-diene-2,5,10,13-tetrone, 8,16-bis(2-oxopropyl)-, [8S-(3E,8R*,11E,16R*)]- 0.0135712240673827 0.31897441
NSC 672055 Null 0.0135712240673827 0.35297823
Total:84  Current:24    [First] [Prev] [Next] [Last]